市場調查報告書
商品編碼
1067178

醫藥品的人工智慧(2022年∼2029年):市場佔有率,規模,趨勢,產業分析報告,各用途,各技術,各提供,各部署,各地區,各市場區隔預測

Artificial Intelligence in Pharmaceutical Market Share, Size, Trends, Industry Analysis Report, By Application ; By Technology; By Offering; By Deployment; By Region; Segment Forecast, 2022 - 2029

出版日期: | 出版商: Polaris Market Research | 英文 121 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球醫藥品的人工智慧的市場規模預計至2029年成為71億4,720萬美元。

本報告提供全球醫藥品的人工智慧市場調查,市場概要,市場的推動因素與阻礙因素的分析,市場機會,COVID-19的影響,各用途,各技術,各提供,各部署,各地區的市場分析,競爭情形,主要企業的簡介等系統性資訊。

目錄

第1章 簡介

  • 報告的說明
    • 調查的目的
    • 市場範圍
    • 假設
  • 利害關係者

第2章 摘要整理

  • 市場概況

第3章 調查手法

  • 概要
    • 資料探勘
  • 資料資訊來源
    • 一級資訊來源
    • 二級資訊來源

第4章 醫藥品的人工智慧:全球市場洞察

  • 產業的概述
  • 市場動態
    • 促進因素和機會
    • 阻礙因素與課題
  • 波特的五力分析
    • 供給企業談判力(中)
    • 新加入廠商的威脅(低)
    • 買方議價能力(中)
    • 替代威脅(中)
    • 現有企業間的競爭(高)
  • 大環境分析
  • 產業趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球醫藥品的人工智慧市場:各用途

  • 主要調查結果
  • 簡介
    • 各用途:2017年∼2029年
  • 藥物研發
    • 各藥物研發,各地區:2017年∼2029年
  • 精準醫學
    • 各精準醫學,各地區:2017年∼2029年
  • 醫療用影像和診斷
    • 各醫療用影像和診斷,各地區:2017年∼2029年
  • 研究
    • 各研究,各地區:2017年∼2029年

第6章 全球醫藥品的人工智慧市場:各技術

  • 主要調查結果
  • 簡介
    • 各技術:2017年∼2029年
  • 機器學習
    • 各機器學習,各地區:2017年∼2029年
  • 自然語言處理
    • 各自然語言處理,各地區:2017年∼2029年
  • 深度學習
    • 各深度學習,各地區:2017年∼2029年
  • 其他
    • 各其他,各地區:2017年∼2029年

第7章 全球醫藥品的人工智慧市場:各提供

  • 主要調查結果
  • 簡介
    • 各提供:2017年∼2029年
  • 硬體設備
    • 各硬體設備,各地區:2017年∼2029年
  • 軟體
    • 各類軟體,各地區:2017年∼2029年
  • 服務
    • 各類服務,各地區:2017年∼2029年

第8章 全球醫藥品的人工智慧市場:各部署

  • 主要調查結果
  • 簡介
    • 各部署:2017年∼2029年
  • 雲端
    • 各雲端,各地區:2017年∼2029年
  • 內部部署
    • 各內部部署,各地區:2017年∼2029年

第9章 全球醫藥品的人工智慧市場:各地區

  • 主要調查結果
  • 簡介
    • 各地區:2017年∼2029年
  • 北美
    • 各用途:2017年∼2029年
    • 各部署:2017年∼2029年
    • 各技術:2017年∼2029年
    • 各提供:2017年∼2029年
    • 美國
    • 加拿大
  • 歐洲
    • 各用途:2017年∼2029年
    • 各部署:2017年∼2029年
    • 各技術:2017年∼2029年
    • 各提供:2017年∼2029年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 奧地利
  • 亞太地區
    • 各用途:2017年∼2029年
    • 各部署:2017年∼2029年
    • 各技術:2017年∼2029年
    • 各提供:2017年∼2029年
    • 中國
    • 印度
    • 日本
    • 馬來西亞
    • 印尼
    • 韓國
  • 中東、非洲
    • 各用途:2017年∼2029年
    • 各部署:2017年∼2029年
    • 各技術:2017年∼2029年
    • 各提供:2017年∼2029年
    • 沙烏地阿拉伯
    • 南非
    • 以色列
    • 阿拉伯聯合大公國
  • 南美
    • 各用途:2017年∼2029年
    • 各部署:2017年∼2029年
    • 各技術:2017年∼2029年
    • 各提供:2017年∼2029年
    • 墨西哥
    • 巴西
    • 阿根廷

第10章 競爭情形

  • 擴張及取得分析
    • 擴張
    • 收購
  • 夥伴關係/合作/契約/展示會

第11章 企業簡介

  • AstraZeneca LLC
  • Atomwise Inc.
  • Bayer AG
  • Cloud Pharmaceuticals Inc
  • GNS Healthcare
  • IBM Watson
  • Merck & Co.
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer Inc.
  • Recursion Pharmaceuticals Inc.
  • XtalPi Inc.
目錄
Product Code: PM2145

The global Artificial Intelligence (AI) in pharmaceutical market size is expected to reach USD 7,147.2 million by 2029 according to a new study by Polaris Market Research. The report "Artificial Intelligence (AI) in Pharmaceutical Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Discovery, Precision Medicine, Medical Imaging & Diagnostics, Research); By Technology; By Offering; By Deployment; By Region; Segment Forecast, 2022 - 2029" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising funding and investment in the R&D activities by the private and public players in the pharma industry is driving the market's growth. As funding rises in the industry, major players' adoption of artificial intelligence in pharmaceuticals also increases for ease of the process. Further, the growing importance of precision medicine and increased investment for R&D for the use of artificial intelligence technology in this industry is expected to contribute to industry expansion.

The introduction of artificial intelligence in the pharma sector results from increasing demand on drugmakers to reduce drug prices. Al reduced clinical trial failure rates while simultaneously eliminating the cost of long-term drug discovery research and development. Various pharma companies have already developed wearables that use artificial intelligence algorithms to remotely monitor patients with life-threatening conditions.

Based on the offering, the software segment accounted for the leading share in 2021. It is due to continued innovation in software that supports the healthcare industry's demand. However, during the forecast period, the hardware category is expected to develop at the fastest rate due to artificial intelligence devices' adoption to assess health information recorded in structured data such as imaging, genetic, and EP information.

Market players such as GNS Healthcare, Atomwise Inc., Bayer AG, Cloud Pharmaceuticals Inc, Recursion Pharmaceuticals Inc., AstraZeneca LLC, XtalPi Inc., Microsoft Corporation, Novartis AG, NVIDIA Corporation, Pfizer Inc., IBM Watson, and Merck & Co. are some key players operating in the global market.

In March 2021, Iktos announced using their artificial intelligence and machine learning for de novo design in selected Pfizer small-molecule discovery initiatives. Pfizer has used Iktos' generative modeling technology in small-molecule initiatives. Makya, Iktos' innovative artificial intelligence-driven de novo tools to improve for Multi-Parametric Optimization (MPO), was introduced earlier this year as a Saas application or for installation on client premises or in the user's Virtual Private Cloud (VPC). Thus, the collaboration among major players to adopt artificial intelligence in the pharma industry boosts market growth during the forecast period.

Polaris Market Research has segmented the Artificial Intelligence (AI) in pharmaceutical market report based on application, offering, technology, deployment, and region:

Artificial Intelligence (AI) in Pharmaceutical, Application Outlook (Revenue - USD Million, 2017 - 2029)

Drug Discovery

Precision Medicine

Medical Imaging & Diagnostics

Research

Artificial Intelligence (AI) in Pharmaceutical, Offering Outlook (Revenue - USD Million, 2017 - 2029)

Hardware

Software

Services

Artificial Intelligence (AI) in Pharmaceutical, Technology Outlook (Revenue - USD Million, 2017 - 2029)

Machine Learning

Natural Language Processing

Deep Learning

Others

Artificial Intelligence (AI) in Pharmaceutical, Deployment Outlook (Revenue - USD Million, 2017 - 2029)

Cloud

On-Premise

Artificial Intelligence (AI) in Pharmaceutical, Regional Outlook (Revenue - USD Million, 2017 - 2029)

North America

U.S.

Canada

Europe

France

Germany

UK

Italy

Spain

Netherlands

Austria

Asia Pacific

China

India

Japan

Malaysia

South Korea

Indonesia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Artificial Intelligence (AI) in Pharmaceutical Market Insights

  • 4.1. Artificial Intelligence (AI) in Pharmaceutical - Industry Snapshot
  • 4.2. Artificial Intelligence (AI) in Pharmaceutical Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. High investment for the fruitful results
      • 4.2.1.2. High failure rates in clinical trials
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High cost of operation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Artificial Intelligence (AI) in Pharmaceutical Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • 5.3. Drug Discovery
    • 5.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Drug Discovery, by Region, 2017 - 2029 (USD Million)
  • 5.4. Precision Medicine
    • 5.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Precision Medicine, by Region, 2017 - 2029 (USD Million)
  • 5.5. Medical Imaging & Diagnostics
    • 5.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Medical Imaging & Diagnostics, by Region, 2017 - 2029 (USD Million)
  • 5.6. Research
    • 5.6.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Research, by Region, 2017 - 2029 (USD Million)

6. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Machine Learning, by Region, 2017 - 2029 (USD Million)
  • 6.4. Natural Language Processing
    • 6.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Natural Language Processing, by Region, 2017 - 2029 (USD Million)
  • 6.5. Deep Learning
    • 6.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deep Learning, by Region, 2017 - 2029 (USD Million)
  • 6.6. Others
    • 6.6.1. Global Other Artificial Intelligence (AI) in Pharmaceutical Market, by Region, 2017 - 2029 (USD Million)

7. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • 7.3. Hardware
    • 7.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Hardware, by Region, 2017 - 2029 (USD Million)
  • 7.4. Software
    • 7.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Software, by Region, 2017 - 2029 (USD Million)
  • 7.5. Services
    • 7.5.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Services, by Region, 2017 - 2029 (USD Million)

8. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • 8.3. Cloud
    • 8.3.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Cloud, by Region, 2017 - 2029 (USD Million)
  • 8.4. On-Premises
    • 8.4.1. Global Artificial Intelligence (AI) in Pharmaceutical Market, by On-Premises, by Region, 2017 - 2029 (USD Million)

9. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Artificial Intelligence (AI) in Pharmaceutical Market Assessment, By Geography, 2017 - 2029 (USD Million)
  • 9.3. Artificial Intelligence (AI) in Pharmaceutical Market - North America
    • 9.3.1. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
    • 9.3.2. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
    • 9.3.3. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
    • 9.3.4. North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.3.5. Artificial Intelligence (AI) in Pharmaceutical Market - U.S.
      • 9.3.5.1. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.3.5.2. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.3.5.3. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.3.5.4. U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.3.6. Artificial Intelligence (AI) in Pharmaceutical Market - Canada
      • 9.3.6.1. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.3.6.2. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.3.6.3. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.3.6.4. Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • 9.4. Artificial Intelligence (AI) in Pharmaceutical Market - Europe
    • 9.4.1. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
    • 9.4.2. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
    • 9.4.3. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
    • 9.4.4. Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.5. Artificial Intelligence (AI) in Pharmaceutical Market - UK
      • 9.4.5.1. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.5.2. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.5.3. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.5.4. UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.6. Artificial Intelligence (AI) in Pharmaceutical Market - France
      • 9.4.6.1. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.6.2. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.6.3. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.6.4. France: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.7. Artificial Intelligence (AI) in Pharmaceutical Market - Germany
      • 9.4.7.1. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.7.2. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.7.3. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.7.4. Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.8. Artificial Intelligence (AI) in Pharmaceutical Market - Italy
      • 9.4.8.1. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.8.2. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.8.3. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.8.4. Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.9. Artificial Intelligence (AI) in Pharmaceutical Market - Spain
      • 9.4.9.1. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.9.2. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.9.3. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.9.4. Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.10. Artificial Intelligence (AI) in Pharmaceutical Market - Netherlands
      • 9.4.10.1. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.10.2. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.10.3. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.10.4. Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.4.11. Artificial Intelligence (AI) in Pharmaceutical Market - Austria
      • 9.4.11.1. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.4.11.2. Austria.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.4.11.3. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.4.11.4. Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • 9.5. Artificial Intelligence (AI) in Pharmaceutical Market - Asia Pacific
    • 9.5.1. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
    • 9.5.2. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
    • 9.5.3. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
    • 9.5.4. Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.5. Artificial Intelligence (AI) in Pharmaceutical Market - China
      • 9.5.5.1. China: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.5.2. China.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.5.3. China: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.5.4. China: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.6. Artificial Intelligence (AI) in Pharmaceutical Market - India
      • 9.5.6.1. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.6.2. India.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.6.3. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.6.4. India: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.7. Artificial Intelligence (AI) in Pharmaceutical Market - Japan
      • 9.5.7.1. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.7.2. Japan.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.7.3. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.7.4. Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.8. Artificial Intelligence (AI) in Pharmaceutical Market - Malaysia
      • 9.5.8.1. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.8.2. Malaysia.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.8.3. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.8.4. Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.9. Artificial Intelligence (AI) in Pharmaceutical Market - Indonesia
      • 9.5.9.1. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.9.2. Indonesia.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.9.3. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.9.4. Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.5.10. Artificial Intelligence (AI) in Pharmaceutical Market - South Korea
      • 9.5.10.1. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.5.10.2. South Korea.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.5.10.3. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.5.10.4. South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • 9.6. Artificial Intelligence (AI) in Pharmaceutical Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
    • 9.6.2. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
    • 9.6.3. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
    • 9.6.4. Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.6.5. Artificial Intelligence (AI) in Pharmaceutical Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.6.5.2. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.6.5.3. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.6.5.4. Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.6.6. Artificial Intelligence (AI) in Pharmaceutical Market - South Africa
      • 9.6.6.1. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.6.6.2. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.6.6.3. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.6.6.4. South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.6.7. Artificial Intelligence (AI) in Pharmaceutical Market - Israel
      • 9.6.7.1. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.6.7.2. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.6.7.3. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.6.7.4. Israel: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.6.8. Artificial Intelligence (AI) in Pharmaceutical Market - UAE
      • 9.6.8.1. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.6.8.2. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.6.8.3. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.6.8.4. UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • 9.7. Artificial Intelligence (AI) in Pharmaceutical Market - Latin America
    • 9.7.1. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
    • 9.7.2. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
    • 9.7.3. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
    • 9.7.4. Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.7.5. Artificial Intelligence (AI) in Pharmaceutical Market - Mexico
      • 9.7.5.1. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.7.5.2. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.7.5.3. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.7.5.4. Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.7.6. Artificial Intelligence (AI) in Pharmaceutical Market - Brazil
      • 9.7.6.1. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.7.6.2. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.7.6.3. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.7.6.4. Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
    • 9.7.7. Artificial Intelligence (AI) in Pharmaceutical Market - Argentina
      • 9.7.7.1. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
      • 9.7.7.2. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
      • 9.7.7.3. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
      • 9.7.7.4. Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AstraZeneca LLC
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Atomwise Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Bayer AG
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Cloud Pharmaceuticals Inc
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. GNS Healthcare
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. IBM Watson
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Merck & Co.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Microsoft Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Novartis AG
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. NVIDIA Corporation
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pfizer Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Recursion Pharmaceuticals Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. XtalPi Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development

List of Tables

  • Table 1 Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application, by Region, 2017 - 2029 (USD Million)
  • Table 2 Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, by Region, 2017 - 2029 (USD Million)
  • Table 3 Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, by Region, 2017 - 2029 (USD Million)
  • Table 4 Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, by Region, 2017 - 2029 (USD Million)
  • Table 5 Artificial Intelligence (AI) in Pharmaceutical Market Assessment, By Geography, 2017 - 2029 (USD Million)
  • Table 6 North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 7 North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 8 North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 9 North America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 10 U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 11 U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 12 U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 13 U.S.: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 14 Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 15 Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 16 Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 17 Canada: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 18 Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 19 Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 20 Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 21 Europe: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 22 Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 23 Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 24 Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 25 Germany: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 26 France: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 27 France: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 28 France: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 29 France: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 30 UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 31 UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 32 UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 33 UK: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 34 Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 35 Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 36 Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 37 Italy: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 38 Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 39 Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 40 Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 41 Netherlands: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 42 Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 43 Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 44 Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 45 Spain: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 46 Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 47 Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 48 Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 49 Austria: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 50 Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 51 Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 52 Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 53 Asia Pacific: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 54 China: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 55 China: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 56 China: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 57 China: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 58 Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 59 Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 60 Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 61 Japan: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 62 India: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 63 India: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 64 India: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 65 India: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 66 Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 67 Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 68 Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 69 Indonesia: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 70 Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 71 Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 72 Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 73 Malaysia: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 74 South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 75 South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 76 South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 77 South Korea: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 78 Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 79 Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 80 Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 81 Latin America: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 82 Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 83 Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 84 Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 85 Brazil: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 86 Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 87 Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 88 Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 89 Mexico: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 90 Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 91 Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 92 Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 93 Argentina: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 94 Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 95 Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 96 Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 97 Middle East & Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 98 UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 99 UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 100 UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 101 UAE: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 102 Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 103 Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 104 Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 105 Saudi Arabia: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 106 South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 107 South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 108 South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 109 South Africa: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)
  • Table 110 Isreal: Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2017 - 2029 (USD Million)
  • Table 111 Isreal: Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2017 - 2029 (USD Million)
  • Table 112 Isreal: Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2017 - 2029 (USD Million)
  • Table 113 Isreal: Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2017 - 2029 (USD Million)

List of Figures

Figure 1. Global Artificial Intelligence (AI) in Pharmaceutical Market, 2017 - 2029 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Deployment

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Application

Figure 7. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Application, 2021 & 2029 (USD Million)

Figure 8. Market by Deployment

Figure 9. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Deployment, 2021 & 2029 (USD Million)

Figure 10. Market by Technology

Figure 11. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Technology, 2021 & 2029 (USD Million)

Figure 12. Market by Offering

Figure 13. Global Artificial Intelligence (AI) in Pharmaceutical Market, by Offering, 2021 & 2029 (USD Million)

Figure 14. Artificial Intelligence (AI) in Pharmaceutical Market Assessment, By Geography, 2017 - 2029 (USD Million)

Figure 15. Strategic Analysis - Artificial Intelligence (AI) in Pharmaceutical Market